Article
Vice President Joshua White Outlines Critical Considerations for Pharmaceutical Industry Mergers at Concurrences Event
Vice President Joshua White provided an overview of the pharmaceutical market and key factors for merger reviews during the “Mergers in the Pharmaceutical Industry” panel at the Concurrences International Mergers Conference. Mr. White outlined the structure of the market and explored features such as the complexities associated with market definition for horizontal mergers and best practices for evaluating theories of harm. He also addressed the questions of over-enforcement in the pharmaceutical industry, in which innovation has a significant impact on public health, and of pricing regulations in the UK, including concerns around high drug prices for innovations such as personalized medicine and gene therapy. Mr. White’s co-panelists explored topics such as recent mergers and trends in merger enforcement worldwide.
Meet Our People
Joshua White
Vice PresidentMr. White is a consulting economist who specializes in applying microeconomics and sophisticated econometric modeling to complex litigation and merger-related questions, primarily in matters involving the health care, financial services, and technology industries. His work across a diverse set of engagements has encompassed simulating consumer demand and switching behavior, analyzing whether intellectual property (IP) licensing rates are FRAND-compliant, and estimating ex ante default probabilities for structured investment vehicles. He also has substantial experience developing innovative technological tools for analyzing datasets for merger and competition analyses.
Mr. White has supported both economic and scientific experts addressing competition and intellectual property (IP) issues in matters related to cutting-edge pharmaceutical products. He has supported clients in various jurisdictions and industries in follow-on cartel damages litigation, assessing overcharge, upstream and downstream pass-on, and volume effects.
Mr. White has worked in a number of international jurisdictions and has served as a testifying expert in the UK’s Upper Tribunal (Lands Chamber) on competition matters related to restrictive land covenants. He has also given evidence and submissions to the UK’s Competition and Markets Authority (CMA) on behalf of clients involved in market investigations and mergers. Mr. White has supported several clients before the European Commission on cartel and merger matters and has provided support to European financial and competition regulators in coordinated conduct investigations. Mr. White has published a number of articles and regularly speaks at international competition law and policy conferences.